What is a stock summary page? Click here for an overview.
Business Description
Dingdang Health Technology Group Ltd
ISIN : KYG2762W1069
Compare
Compare
Traded in other countries / regions
09886.Hong Kong Index Membership
Hong Kong Stock Connect IPO Date
2022-09-14Description
Dingdang Health Technology Group Ltd is an investment holding company and its subsidiaries are principally engaged in the provision of pharmaceutical and healthcare business in the PRC. It is transforming and reshaping China's healthcare industry by pioneering on-demand pharmaceutical retail and medical consultation, with online-to-offline solutions.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 7.98 | |||||
| Equity-to-Asset | 0.63 | |||||
| Debt-to-Equity | 0.09 | |||||
| Debt-to-EBITDA | -0.42 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | -1.22 | |||||
| Beneish M-Score | -3.38 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 3.9 | |||||
| 3-Year EBITDA Growth Rate | 39.3 | |||||
| 3-Year EPS without NRI Growth Rate | 38.3 | |||||
| 3-Year FCF Growth Rate | 68.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 29.11 | |||||
| 9-Day RSI | 27.87 | |||||
| 14-Day RSI | 29.91 | |||||
| 3-1 Month Momentum % | 14.61 | |||||
| 6-1 Month Momentum % | -15 | |||||
| 12-1 Month Momentum % | -50.96 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.65 | |||||
| Quick Ratio | 1.96 | |||||
| Cash Ratio | 1.46 | |||||
| Days Inventory | 70.77 | |||||
| Days Sales Outstanding | 22.31 | |||||
| Days Payable | 48.3 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 0.5 | |||||
| Shareholder Yield % | -2.29 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 32.95 | |||||
| Operating Margin % | -4.31 | |||||
| Net Margin % | -8.05 | |||||
| FCF Margin % | -0.53 | |||||
| ROE % | -19.82 | |||||
| ROA % | -12.88 | |||||
| ROIC % | -22.81 | |||||
| 3-Year ROIIC % | -243.29 | |||||
| ROC (Joel Greenblatt) % | -106.27 | |||||
| ROCE % | -17.8 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 30.45 | |||||
| PS Ratio | 0.1 | |||||
| PB Ratio | 0.25 | |||||
| Price-to-Tangible-Book | 0.27 | |||||
| EV-to-EBIT | 1.72 | |||||
| EV-to-Forward-EBIT | -0.96 | |||||
| EV-to-EBITDA | 1.72 | |||||
| EV-to-Revenue | -0.13 | |||||
| EV-to-Forward-Revenue | 0.03 | |||||
| EV-to-FCF | 23.85 | |||||
| Price-to-Net-Current-Asset-Value | 0.34 | |||||
| Price-to-Net-Cash | 1.68 | |||||
| Earnings Yield (Greenblatt) % | 58.14 | |||||
| FCF Yield % | -5.96 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers